https://socictopen.socict.org/files/original/df34c63bba11a053436f6200d644003b.pdf ca8565e7d5520b1a7f12caa4747eea4b Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Construction of Epitope-Based Peptide Vaccine Against SARS-CoV-2: Immunoinformatics Study Creator An entity primarily responsible for making the resource Arif Nur Muhammad Ansori, Viol Dhea Kharisma Description An account of the resource Recently, a novel coronavirus (SARS-CoV-2) appeared which is conscientious for the current outbreakin China and rapidly spread worldwide. Unluckily, there is no approved vaccine found against SARSCoV-2. Therefore, there is an urgent need for designing a suitable peptide vaccine constituent againstthe SARS-CoV-2. In this study, we characterized the spike glycoprotein of SARS-CoV-2 to obtainimmunogenic epitopes. In addition, we used 58 SARS-CoV-2 isolates were retrieved from the GlobalInitiative on Sharing All Influenza Data (GISAID) and National Center for Biotechnology Information(NCBI), then aligned to obtain the conserved region of SARS-CoV-2 spike glycoprotein. The interactionbetween the conserved region with ACE2 receptor, a SARS-CoV-2 receptor on the host cell, has beenevaluated through molecular docking approach. The B-cell epitope was identified using the immuneepitope database (IEDB) web server. Interestingly, we recommend Pep_4 ADHQPQTFVNTELH as aepitope-based peptide vaccine candidate to deal with the SARS-CoV-2 outbreak. Pep_4 has a high levelof immunogenicity and does not trigger autoimmune mechanisms. Pep_4 is capable of forming BCR/Fab molecular complexes with the lowest binding energy for activation of transduction signal the directB-cell immune response. However, further study is suggested for confirmation (in vitro and in vivo). Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource coronavirus, immunoinformatics, SARS-CoV-2, epitope-based peptide vaccine Identifier An unambiguous reference to the resource within a given context DOI: 10.22207/JPAM.14.SPL1.38 Source A related resource from which the described resource is derived Journal of Pure and Applied Microbiology Publisher An entity responsible for making the resource available Journal of Pure and Applied Microbiology Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Microbiology